INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Fire engulfs Bloomington's Village Deli
A fire broke out Sunday afternoon at a beloved Bloomington eatery.
South Bend council seeks release of recordings
SOUTH BEND, Ind. (AP) -- Attorneys for South Bend's city council are seeking the immediate release of telephone recordings at the center of…
Indiana lawmakers facing renewed casinos debate
Indiana lawmakers are facing a new debate over whether to let the state's riverboat casinos move to on-land sites and allow live dealers…
Johnson Co. Sheriff investigates $2.8k fraud
A Johnson County woman says she was scammed out of more than $2,800 she paid to an online company for kitchen cabinets.
Woman arrested after stabbing in Westfield home
A woman was arrested early Sunday after a stabbing during a domestic disturbance at a home in Westfield.
RTV6 day at the Indianapolis Home Show
RTV6 anchors and reporters greeted thousands of fans Saturday at the 2015 Indianapolis Home Show.